Skip to Main Content

Paper Details

Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models.
Elife
4
2022
AML, AML models, acute myeloid leukemia, cancer, cancer cells, cell types, compaRe, genes, immune cells, mouse, myelodysplastic syndrome, patients
Author NameAffiliation
Krister WennerbergBiotech Research and Innovation Centre (BRIC) and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen
Kyoung-Jae WonBiotech Research and Innovation Centre (BRIC) and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen
  • 1 - 2

Datasets

Release 1.2